Reisman L, Lin W G, Martinelli G P
Department of Pediatrics, Mount Sinai School of Medicine, New York 10029, USA.
Transpl Immunol. 1995 Mar;3(1):45-9. doi: 10.1016/0966-3274(95)80005-0.
This study evaluates the ability of the immunosuppressive drugs dexamethasone, cyclosporine, FK506 and rapamycin, alone and in combination to suppress interleukin-1 beta (IL-1 beta) secretion in vitro by THP-1 cells when stimulated by lipopolysaccharide. All four drugs, when added to cell culture medium at therapeutic concentrations, significantly decrease secretion of the monokine to well below control levels. However, only dexamethasone completely suppresses IL-1 beta secretion in a dose-dependent fashion. Cyclosporine, FK506 and rapamycin only partially suppress secretion of IL-1 beta at concentrations within their therapeutic ranges and increasing concentrations of the drugs do not result in further suppression of secretion. Likewise, the combination of any two of these three drugs does not provide any additional suppressive effect. Dexamethasone, however, when added in increasing concentrations in combination with any of the other drugs, results in further suppression of IL-1 secretion in a dose-dependent fashion. These data suggest that cyclosporine, FK506 and rapamycin all share a common effect on the production of IL-1 beta, different from that of dexamethasone.
本研究评估了免疫抑制药物地塞米松、环孢素、FK506和雷帕霉素单独及联合使用时,在体外抑制脂多糖刺激THP-1细胞分泌白细胞介素-1β(IL-1β)的能力。当以治疗浓度添加到细胞培养基中时,所有四种药物均能显著降低单核因子的分泌,使其远低于对照水平。然而,只有地塞米松能以剂量依赖的方式完全抑制IL-1β的分泌。环孢素、FK506和雷帕霉素在其治疗浓度范围内仅部分抑制IL-1β的分泌,且药物浓度增加并不会导致分泌进一步受到抑制。同样,这三种药物中任意两种联合使用也不会产生额外的抑制作用。然而,地塞米松与其他任何一种药物联合使用并增加其浓度时,会以剂量依赖的方式进一步抑制IL-1的分泌。这些数据表明,环孢素、FK506和雷帕霉素对IL-1β的产生具有共同作用,这与地塞米松不同。